Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trichuris trichiura egg inoculum refers to a preparation containing the embryonated eggs of the parasitic roundworm Trichuris trichiura, also known as whipworm. These eggs are barrel-shaped, thick-shelled, and possess polar plugs at each end[1][7]. When ingested by humans, the eggs hatch in the small intestine—mediated by contact with intestinal bacteria—and develop into adult worms in the large intestine[5][8]. The mechanism of action is based on deliberate infection with T. trichiura to modulate host immune responses; this approach has been explored experimentally for potential therapeutic effects in immune-mediated diseases such as inflammatory bowel disease (IBD) and other autoimmune conditions. The primary indication under investigation is immunomodulation via controlled helminthic therapy rather than direct anti-infective use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on trichuris trichiura egg inoculum.